Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.00
Bid: 37.00
Ask: 39.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.405%)
Open: 38.00
High: 38.00
Low: 38.00
Prev. Close: 38.00
MIG1 Live PriceLast checked at -
Maven Income and Growth VCT is an Investment Trust

To achieve long term capital appreciation and generate maintainable levels of income for shareholders through investing in small and medium sized unlisted and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

5 Apr 2013 18:07

RNS Number : 7437B
Maven Income & Growth VCT PLC
05 April 2013
 



Maven Income and Growth VCT PLC

Minutes of a Meeting of Directors of the Company held by telephone on Friday 5 April 2013 at 4.30 p.m.

Present: Mr J D W Pocock (in the Chair)

Mr A G MacMillan

Sir C G Stuart-Menteth Bt

Mrs F E Wollocombe

In attendance: Maven Capital Partners UK LLP, Secretary, represented by Mr D Russell.

1. Quorum and Declaration of Interests

The Chairman announced the presence of a quorum and that in accordance with the Articles of Association of the Company a Director could participate in a Meeting of the Board by telephone. Accordingly, the Chairman declared the Meeting duly convened and competent to proceed to business.

Each of the Directors declared his interests in the matters to be transacted at the Meeting. The Chairman noted that in terms of the Articles of Association of the Company, each of the Directors could, following his declaration of interests, be counted in the quorum and vote on the matters to be transacted at the Meeting notwithstanding his interests.

2. Purpose of the Meeting

The Chairman explained that valid applications totalling £983,113.24 had been received from investors under the Offer for Subscription (the Offer) in respect of the 2012/2013 tax year. Under the terms of the Offers Document dated 23 January 2013, these applications represented 1,394,963 Ordinary Shares and it was proposed that such applications should be accepted and Ordinary Shares allotted to the successful applicants.

 

3. Allotment of Ordinary Shares under the Offer

A schedule (the Applications Schedule) prepared by Capita Registrars detailing those applicants who had applied to subscribe for Ordinary Shares under the Offer during the period from 5 March 2013 to 5 April 2013 (the Second Closure Period) was tabled to the Meeting. It was noted that during the Second Closure Period, the Company had received applications from investors to subscribe for 1,394,963 Ordinary Shares under the Offer (including in respect of commission waived by financial advisers on those applications and the early investment incentive) in respect of the 2012/2013 tax year.

It was noted that cheques and/or bankers' drafts in the appropriate amounts had been received by Capita Registrars in respect of the Applications, but that not all of such cheques and/or bankers' drafts had cleared as of the time and date of the Meeting. It was further noted that the Board had a general and unconditional authority to allot equity securities under the Offer up to a nominal amount of £411,663 as if section 561(1) of the Companies Act 2006 did not apply.

It was noted that these applications included those from partners or key employees of Maven Capital Partners UK LLP and, as such, represented related party transaction. However, it had been confirmed that appropriate checks had been carried out to verify that these applications were below the level that required prior approval by the UKLA or Shareholders.

Having carefully considered the Applications Schedule, it was agreed and resolved that, conditional in each case on the receipt of cleared funds under each Application:

3.1.1. the Applications in the names of the persons set out in the Applications Schedule be accepted in full with immediate effect;

3.1.2. 1,394,963 Ordinary Shares in aggregate be allotted to the successful applicants under the Offer;

3.1.3. Capita Registrars be and is hereby authorised and instructed to prepare and despatch share and tax certificates to the successful applicants or to instruct credits to the appropriate CREST accounts of the successful applicants and to insert details of each such applicant in the Register of Allotments and the Register of Members of the Company;

3.1.4. the Secretary be authorised to make applications to the UK Listing Authority and London Stock Exchange plc for such Ordinary Shares to be admitted to the Official List and to trading on the main market of London Stock Exchange plc and to arrange for any necessary announcements to be made to a Regulatory Information Service in connection with the allotment; and

3.1.5. the Secretary was instructed to file a Form SH01 at Companies House in respect of the allotment of Ordinary Shares under the Offer.

There being no further business, the Meeting then concluded.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEDELFBXZFBBBZ
Date   Source Headline
1st May 202410:02 amRNSIssue of Equity
26th Apr 20241:33 pmRNSUnaudited NAV & Proposed Final Dividend
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:47 pmRNSIssue of Equity
27th Mar 202410:34 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
21st Mar 20243:55 pmRNSStatement re Offer for Subscription
20th Mar 20243:44 pmRNSUnaudited Net Asset Value
8th Feb 202410:27 amRNSDirector/PDMR Shareholding
8th Feb 202410:26 amRNSDirector/PDMR Shareholding
8th Feb 202410:08 amRNSIssue of Equity
30th Jan 20245:09 pmRNSTransaction in Own Shares
17th Jan 20249:59 amRNSDirector/PDMR Shareholding
17th Jan 20249:57 amRNSIssue of Equity
15th Jan 20244:25 pmRNSUnaudited Net Value Asset
1st Dec 20239:39 amRNSIssue of Equity
24th Nov 202312:04 pmRNSStatement re Dividend Investment Scheme
9th Nov 20233:35 pmRNSResult of General Meeting
19th Oct 20234:51 pmRNSTransaction in Own Shares
18th Oct 20233:54 pmRNSHalf-year Report
13th Oct 20234:56 pmRNSPublication of a Prospectus
5th Oct 20234:39 pmRNSNet Asset Value and Interim Dividend
20th Jul 20234:32 pmRNSTransaction in Own Shares
14th Jul 20239:26 amRNSIssue of Equity
7th Jul 20234:17 pmRNSStatement re Dividend Investment Scheme
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
6th Jul 20233:37 pmRNSNet Asset Value
6th Jul 20231:06 pmRNSResult of AGM
7th Jun 20234:21 pmRNSAnnual Financial Report
2nd Jun 20239:39 amRNSIssue of Equity
1st Jun 202312:18 pmRNSNet Asset Value(s)
26th May 20233:53 pmRNSTransaction in Own Shares
24th May 202310:52 amRNSUnaudited NAV and Proposed Final Dividend
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
5th Apr 202312:33 pmRNSDirector/PDMR Shareholding
5th Apr 202312:26 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
3rd Mar 202310:37 amRNSDirector/PDMR Shareholding
3rd Mar 202310:35 amRNSDirector/PDMR Shareholding
3rd Mar 202310:35 amRNSDirector/PDMR Shareholding
3rd Mar 20239:47 amRNSIssue of Equity
21st Feb 20234:39 pmRNSTransaction in Own Shares
6th Feb 20234:23 pmRNSNet Asset Value(s)
2nd Dec 20229:30 amRNSIssue of Equity
25th Nov 202212:36 pmRNSStatement re Dividend Investment Scheme
9th Nov 20222:34 pmRNSResult of General Meeting
4th Nov 202211:15 amRNSHalf-year Report
26th Oct 20223:50 pmRNSTransaction in Own Shares
14th Oct 20223:33 pmRNSNet Asset Value and Interim Dividend
7th Oct 20224:28 pmRNSPublication of a Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.